Trial intelligence / Profile preview

Hangover Effect of Songha Night in Healthy Adults

NCT02273453Phase 1Completed

Sponsor
Boehringer Ingelheim
Start
Feb 2003
Primary completion
Jun 2003
Modality
Small Molecules
01

Overview

Phase 1, randomised, double-blind trial of Songha Night in Insomnia (3 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Pupillary Unrest Index at Day 7. Started Feb 2003; status: completed.

02

Drugs

Songha Night
03

Conditions

Insomnia

Beyond the preview

Go deeper on NCT02273453.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02273453.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call